PMID- 30470408
OWN - NLM
STAT- MEDLINE
DCOM- 20190111
LR  - 20190111
IS  - 1558-1349 (Electronic)
IS  - 1042-3680 (Linking)
VI  - 30
IP  - 1
DP  - 2019 Jan
TI  - Evidence for Improving Outcome Through Extent of Resection.
PG  - 85-93
LID - S1042-3680(18)30886-6 [pii]
LID - 10.1016/j.nec.2018.08.005 [doi]
AB  - Surgical resection plays a central role in the management of gliomas however many
      tumors are within areas resulting in sensorimotor and cognitive consequences.
      This article reviews the evidence in support of extent of resection to improve
      survival, symptom management, and time to malignant transformation in low-grade
      gliomas. The authors summarize the evolving literature regarding the role of
      maximal safe resection in light of WHO subclassification of low-grade gliomas.
      Long lasting neurological deficits following glioma resection may hinder both
      survival and quality of life. New insights into glioma related central nervous
      system plasticity impact both surgical planning and timing of interventions.
CI  - Copyright (c) 2018 Elsevier Inc. All rights reserved.
FAU - Hervey-Jumper, Shawn L
AU  - Hervey-Jumper SL
AD  - Department of Neurological Surgery, University of California San Francisco, 513
      Parnassus Avenue, Health Sciences East Suite 814, San Francisco, CA 94143-0112,
      USA. Electronic address: Shawn.Hervey-Jumper@ucsf.edu.
FAU - Berger, Mitchel S
AU  - Berger MS
AD  - Department of Neurological Surgery, University of California San Francisco, 505
      Parnassus Avenue, M779, San Francisco, CA 94143-0112, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20181101
PL  - United States
TA  - Neurosurg Clin N Am
JT  - Neurosurgery clinics of North America
JID - 9008004
SB  - IM
MH  - Brain Neoplasms/pathology/*surgery
MH  - Glioma/pathology/*surgery
MH  - Humans
MH  - Neoplasm Recurrence, Local/*surgery
MH  - *Neurosurgical Procedures
MH  - Quality of Life
MH  - *Treatment Outcome
OTO - NOTNLM
OT  - Astrocytoma
OT  - Extent of resection
OT  - Low-grade glioma
OT  - Oligodendroglioma
OT  - Volume of residual
EDAT- 2018/11/25 06:00
MHDA- 2019/01/12 06:00
CRDT- 2018/11/25 06:00
PHST- 2018/11/25 06:00 [entrez]
PHST- 2018/11/25 06:00 [pubmed]
PHST- 2019/01/12 06:00 [medline]
AID - S1042-3680(18)30886-6 [pii]
AID - 10.1016/j.nec.2018.08.005 [doi]
PST - ppublish
SO  - Neurosurg Clin N Am. 2019 Jan;30(1):85-93. doi: 10.1016/j.nec.2018.08.005. Epub
      2018 Nov 1.